Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Vaccination and infection prevention in patients with myeloma: current practices & future outlooks

Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, discusses the importance of vaccination and infection prevention in patients with multiple myeloma, highlighting the increased rates of infection observed in recent years with the introduction of novel immunotherapies. Dr Ramasamy also comments on areas requiring further research, including the use of intravenous immunoglobulins in this patient population. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.